NFKB1 and hepatocellular carcinoma: Furthermore, 18β-glycyrrhetinic acid improves the efficacy of radiotherapy in HCC by inhibiting EGFR/ERK/NF-κB signaling and promoting radiotherapy-induced apoptotic pathways [30].